Risk of bias tools for medication adherence research: RoBIAS and RoBOAS
British Journal of Clinical Pharmacology · 2025-05 · 91 (5) · 1457-1478
DOI: 10.1111/bcp.16382 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, online erschienen am 21.01.2025. Verfasst von Klarissa A Sinnappah und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Research Design, Medication Adherence. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
An unbiased means of documenting medication‐taking is important to ensure quality evidence about adherence research and to accurately identify individuals at risk of suboptimal adherence for the development of targeted and effective interventions. Guidance to assist researchers in the understanding of risk of bias when conducting or reviewing adherence research is currently not available. To address this gap, tools to identify and gauge the magnitude of important biases that may impact adherence research have been developed.
Methods
The Risk of Bias tool for Interventional Adherence Studies (RoBIAS) and the Risk of Bias tool for Observational Adherence Studies (RoBOAS) were constructed from a literature review of key adherence guidelines/frameworks, drafted initially through author consensus. The draft bias tools were piloted and evaluated with expert adherence researchers through an online survey platform to assess the internal consistency and agreement in responses, including gather “free text” feedback to improve the tool's utility.
Results
Of the 121 approached reviewers, only 20 out of the 30 reviewers who consented to participate completed the piloting of the tools. Both tools are structured around four domains relating to: (i) study design, (ii) randomization (RoBIAS tool) and confounding factors (RoBOAS tool), (iii) adherence outcome measurement, and (iv) data analysis. Each domain consists of items/statements, mapped to specific biases relevant to adherence research and study designs, including a domain‐based ranking scale to determine the appropriate risk of bias judgement.
Conclusions
The tools are intended to have utility when systematically reviewing adherence research and to inform the design of future adherence studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Pharmacy, University of Otago, Dunedin, New Zealand.
- Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK.
- Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
- Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, Australia.
- St Vincent's Clinical Campus, UNSW Medicine, Sydney, Australia.
ORCID-Profile: Klarissa A Sinnappah, Dyfrig A Hughes, Sophie L Stocker, Daniel F B Wright
Zitieren
APA
Sinnappah, K. A., Hughes, D. A., Stocker, S. L., Wright, D. F. B., & ESPACOMP the International Society for Medication Adherence (2025). Risk of bias tools for medication adherence research: RoBIAS and RoBOAS. British Journal of Clinical Pharmacology, 91(5), 1457-1478. https://doi.org/10.1111/bcp.16382
Vancouver
Sinnappah KA, Hughes DA, Stocker SL, Wright DFB, ESPACOMP the International Society for Medication Adherence. Risk of bias tools for medication adherence research: RoBIAS and RoBOAS. British Journal of Clinical Pharmacology. 2025;91(5):1457-1478. doi:10.1111/bcp.16382
BibTeX
@article{Sinnappah2025,
author = {Sinnappah, Klarissa A and Hughes, Dyfrig A and Stocker, Sophie L and Wright, Daniel F B and ESPACOMP the International Society for Medication Adherence, ESPACOMP the International Society for Medication Adherence},
title = {Risk of bias tools for medication adherence research: RoBIAS and RoBOAS},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
volume = {91},
number = {5},
pages = {1457--1478},
doi = {10.1111/bcp.16382}
}
EUVIMED